PRESS RELEASE published on 07/16/2025 at 07:00, 1 year 2 months ago Communiqué de presse : Le SAR446597 de Sanofi a obtenu la désignation « fast track » aux États-Unis pour le traitement de l’atrophie géographique liée à la dégénérescence maculaire liée à l’âge Sanofi obtient la désignation 'fast track' pour le traitement innovant de l'atrophie géographique liée à la dégénérescence maculaire. Le SAR446597 vise à inhiber des voies clés du complément pour une meilleure efficacité Thérapie Génique Sanofi Dégénérescence Maculaire Fast Track Atrophie Géographique
PRESS RELEASE published on 07/16/2025 at 07:00, 1 year 2 months ago Press Release: Sanofi’s SAR446597 earns fast track designation in the US for geographic atrophy due to age-related macular degeneration Sanofi's SAR446597 receives fast track designation in the US for geographic atrophy due to age-related macular degeneration, aiming to address unmet medical needs with innovative gene therapy Gene Therapy Sanofi Fast Track Designation Geographic Atrophy SAR446597
PRESS RELEASE published on 07/15/2025 at 18:30, 1 year 2 months ago Sanofi: Disclosure of trading in own shares
PRESS RELEASE published on 07/15/2025 at 18:30, 1 year 2 months ago Sanofi : Déclaration des transactions sur actions propres
PRESS RELEASE published on 06/30/2025 at 21:33, 1 year 2 months ago Sanofi: Disclosure of trading in own shares
PRESS RELEASE published on 06/30/2025 at 21:33, 1 year 2 months ago Sanofi : Déclaration des transactions sur actions propres
BRIEF published on 06/30/2025 at 07:35, 1 year 2 months ago Sanofi Releases Q2 2025 Aide Mémoire Forward-looking Statements Investor Information Financial Modeling Aide Mémoire Sanofi Q2 2025
BRIEF published on 06/30/2025 at 07:35, 1 year 2 months ago Sanofi publie son aide-mémoire pour le deuxième trimestre 2025 Informations Pour Les Investisseurs Énoncés Prospectifs Modélisation Financière Aide-mémoire Sanofi T2 2025
PRESS RELEASE published on 06/30/2025 at 07:30, 1 year 2 months ago Press release: Availability of the Q2 2025 Aide mémoire Sanofi releases Q2 2025 Aide mémoire for financial modelling, to be published on July 31, 2025. Company details its commitment to innovation and impact in healthcare Innovation Sanofi Aide Mémoire Financial Modelling Q2 2025
BRIEF published on 06/25/2025 at 07:05, 1 year 3 months ago Le riliprubart obtient le statut de médicament orphelin aux États-Unis FDA Transplantation Rénale Médicament Orphelin Immunologie Riliprubart
Published on 09/26/2026 at 01:00, 1 day 9 hours ago Findev Inc. Provides Update on Victoria Park Loan Exposure and Expected Accounting Impairment
Published on 09/25/2026 at 22:15, 1 day 12 hours ago Rocky Shore Gold Closes First Tranche of Non-Brokered Private Placement
Published on 09/25/2026 at 17:30, 1 day 17 hours ago Goldcliff Announces Unit and Flow Through "LIFE" Offerings
Published on 09/25/2026 at 15:00, 1 day 19 hours ago HM Exploration Provides Program Update for the Lewis Pilley's Project
Published on 09/26/2026 at 15:30, 19 hours ago QUORRA X5 fait ses débuts mondiaux à REHACARE International 2026 en Allemagne
Published on 09/26/2026 at 15:30, 19 hours ago QUORRA X5 Makes Its Global Debut at REHACARE International 2026 in Germany
Published on 09/26/2026 at 15:15, 19 hours 15 minutes ago Timur Turlov Elected FIDE President, Becomes First Kazakh to Lead World Chess
Published on 09/26/2026 at 07:45, 1 day 2 hours ago Green SM Begins Pilot Operations In The Netherlands, Further Expanding Its Presence In Europe
Published on 09/26/2026 at 00:01, 1 day 10 hours ago Photon Energy N.V. Sells 7.6 MWp of PV Operational Assets in Slovakia
Published on 09/25/2026 at 17:45, 1 day 16 hours ago COGRA : ASSEMBLÉE GÉNÉRALE MIXTE DU 16 OCTOBRE 2026 / MISE À DISPOSITION DU RAPPORT FINANCIER ANNUEL 2025/2026
Published on 09/25/2026 at 17:40, 1 day 16 hours ago Availability of the 2026 half-year financial report